Baron group reports 3.75% CareDx ownership
CareDx, Inc. received an amended Schedule 13G from Baron Capital Group, Inc., its affiliates BAMCO, Inc. and Baron Capital Management, Inc., and Ronald Baron regarding ownership of CareDx common stock (CUSIP 14167L103).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CareDx, Inc. received an amended Schedule 13G from Baron Capital Group, Inc., its affiliates BAMCO, Inc. and Baron Capital Management, Inc., and Ronald Baron regarding ownership of CareDx common stock (CUSIP 14167L103).
The filing reports that Baron Capital Group, Inc. and Ronald Baron each beneficially own 1,937,326 shares of CareDx common stock, representing 3.75% of the class, with shared voting and dispositive power over all such shares and no sole voting or dispositive power. Within this total, BAMCO, Inc. has shared voting and dispositive power over 1,662,887 shares (about 3.22% of the class), and Baron Capital Management, Inc. has shared voting and dispositive power over 274,439 shares (about 0.53% of the class). The filing confirms that this ownership is now 5 percent or less of the outstanding common stock and that advisory clients of BAMCO and BCM have the economic rights to dividends and sale proceeds in their accounts.
Key Figures
Key Terms
beneficially owned financial
parent holding company financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of CareDx (CDNA) does Baron Capital Group currently report owning?
What is Baron Capital Management, Inc.’s reported position in CareDx (CDNA)?
Does the Baron group still hold more than 5% of CareDx (CDNA) common stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.